| Identification | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | 1,4-Dithiothreitol | ||||||||||||||||||||||||||||||||||||||||||
| Accession Number | DB04447 (EXPT01291) | ||||||||||||||||||||||||||||||||||||||||||
| Type | small molecule | ||||||||||||||||||||||||||||||||||||||||||
| Groups | experimental | ||||||||||||||||||||||||||||||||||||||||||
| Description | A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem] |
||||||||||||||||||||||||||||||||||||||||||
| Structure |
Download: MOL | SDF | SMILES | InChI Display: 2D Structure | 3D Structure |
||||||||||||||||||||||||||||||||||||||||||
| Synonyms | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Salts | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Brand names | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Brand mixtures | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Categories | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| CAS number | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Weight |
Average: 154.251 Monoisotopic: 154.012220944 |
||||||||||||||||||||||||||||||||||||||||||
| Chemical Formula | C4H10O2S2 | ||||||||||||||||||||||||||||||||||||||||||
| InChI Key | InChIKey=VHJLVAABSRFDPM-QWWZWVQMSA-N | ||||||||||||||||||||||||||||||||||||||||||
| InChI |
InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m1/s1
Plain Text
|
||||||||||||||||||||||||||||||||||||||||||
| IUPAC Name |
(2S,3S)-1,4-disulfanylbutane-2,3-diol
|
||||||||||||||||||||||||||||||||||||||||||
| SMILES |
O[C@H](CS)[C@H](O)CS
Plain Text
|
||||||||||||||||||||||||||||||||||||||||||
| Mass Spec | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Taxonomy | |||||||||||||||||||||||||||||||||||||||||||
| Kingdom | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Classes | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Substructures | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Pharmacology | |||||||||||||||||||||||||||||||||||||||||||
| Indication | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Pharmacodynamics | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Mechanism of action | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Absorption | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Volume of distribution | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Protein binding | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Metabolism | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Route of elimination | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Half life | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Clearance | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Toxicity | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Affected organisms | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Pathways | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Pharmacoeconomics | |||||||||||||||||||||||||||||||||||||||||||
| Manufacturers | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Packagers | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Dosage forms | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Prices | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Patents | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Properties | |||||||||||||||||||||||||||||||||||||||||||
| State | solid | ||||||||||||||||||||||||||||||||||||||||||
| Experimental Properties | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Predicted Properties |
|
||||||||||||||||||||||||||||||||||||||||||
| References | |||||||||||||||||||||||||||||||||||||||||||
| Synthesis Reference | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| General Reference | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| External Links |
|
||||||||||||||||||||||||||||||||||||||||||
| ATC Codes | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| AHFS Codes | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| PDB Entries | |||||||||||||||||||||||||||||||||||||||||||
| FDA label | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| MSDS | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||||||||||||||||||
| Drug Interactions | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Food Interactions | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Targets |
|---|
|
1. Protease synthase and sporulation negative regulatory protein PAI 1 Pharmacological action: unknownPossesses N1-acetyltransferase activity toward polyamine substrates including spermidine and spermine. capable of acetylating both spermidine and spermine. In this way it may function in regulating intracellular polyamine concentrations and/or binding capabilities. In addition to preventing toxicity due to polyamine excess, this function may also serve to regulate expression of certain bacterial gene products such as those involved in sporulation Organism class: bacterialUniProt ID: P21340 ![]() Gene: paiA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 2. Holo-[acyl-carrier-protein] synthase Pharmacological action: unknownTransfers the 4'-phosphopantetheine moiety from coenzyme A to a Ser of fatty acid acyl-carrier-protein ACP. Also modifies the D-alanyl carrier protein but fails to recognize PCP and acpK, an acyl carrier protein of secondary metabolism Organism class: bacterialUniProt ID: P96618 ![]() Gene: acpS Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Catalyzes the sequential NAD-dependent oxidations of L- histidinol to L-histidinaldehyde and then to L-histidine Organism class: bacterialUniProt ID: P06988 ![]() Gene: hisD Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Shikimate + NADP(+) = 3-dehydroshikimate + NADPH Organism class: bacterialUniProt ID: P15770 ![]() Gene: aroE Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 5. Galectin-1 Pharmacological action: unknownOrganism class: human UniProt ID: P09382 ![]() Gene: LGALS1 SNPs: SNPJam Report ![]() References:
6. Calcium/calmodulin-dependent protein kinase type II alpha chain Pharmacological action: unknownCaM-kinase II (CAMK2) is a prominent kinase in the central nervous system that may function in long-term potentiation and neurotransmitter release. Member of the NMDAR signaling complex in excitatory synapses it may regulate NMDAR-dependent potentiation of the AMPAR and synaptic plasticity (By similarity) Organism class: humanUniProt ID: Q9UQM7 ![]() Gene: CAMK2A ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Found on the solvent side of the large subunit Organism class: bacterialUniProt ID: P60493 ![]() Gene: rpmA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]()
Pharmacological action: unknown
Binds free retinal and cellular retinol-binding protein- bound retinal. Can convert/oxidize retinaldehyde to retinoic acid Organism class: humanUniProt ID: P00352 ![]() Gene: ALDH1A1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
9. Organic hydroperoxide resistance protein Pharmacological action: unknownOrganism class: bacterial UniProt ID: Q9HZZ3 ![]() Gene: ohr Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 10. 3-carboxy-cis,cis-muconate cycloisomerase Pharmacological action: unknownCatalyzes an anti cycloisomerization Organism class: bacterialUniProt ID: P32427 ![]() Gene: pcaB Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 11. Transient receptor potential cation channel subfamily M member 7 Pharmacological action: unknownOrganism class: human UniProt ID: Q96QT4 ![]() Gene: TRPM7 SNPs: SNPJam Report ![]() References:
12. Unsaturated glucuronyl hydrolase Pharmacological action: unknownCatalyzes the hydrolysis of oligosaccharides with unsaturated glucuronyl residues at the nonreducing terminal, to a sugar or an amino sugar, and an unsaturated D-glucuronic acid (GlcA), which is nonenzymatically converted immediately to alpha- keto acid Organism class: bacterialUniProt ID: Q9RC92 ![]() Gene: ugl Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 13. Molybdenum cofactor biosynthesis protein A Pharmacological action: unknownTogether with moaC, is involved in the conversion of a guanosine derivative (5'-GTP) into molybdopterin precursor Z (By similarity) Organism class: bacterialUniProt ID: P65389 ![]() Gene: moaA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]()
Pharmacological action: unknown
May play a role in both virulence and immunity Organism class: bacterialUniProt ID: Q02192 ![]() Gene: bca Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 15. Peptide methionine sulfoxide reductase Pharmacological action: unknownHas an important function as a repair enzyme for proteins that have been inactivated by oxidation. Catalyzes the reversible oxidation-reduction of methionine sulfoxide in proteins to methionine Organism class: humanUniProt ID: Q9UJ68 ![]() Gene: MSRA ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Involved in the biogenesis of torA. Acts on torA before the insertion of the molybdenum cofactor and, as a result, probably favors a conformation of the apoenzyme that is competent for acquiring the cofactor Organism class: bacterialUniProt ID: O87949 ![]() Gene: torD Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 17. Axin-1 Pharmacological action: unknownInhibitor of the Wnt signaling pathway. Down-regulates beta-catenin. Probably facilitate the phosphorylation of beta- catenin and APC by GSK3B. Likely to function as a tumor suppressor. Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation. Wild-type axin 1 can induce apoptosis in hepatocellular and colorectal cancer cells. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7 Organism class: humanUniProt ID: O15169 ![]() Gene: AXIN1 Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() 18. Peptidyl-prolyl cis-trans isomerase B Pharmacological action: unknownPPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides Organism class: humanUniProt ID: P23284 ![]() Gene: PPIB ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
19. Amylosucrase Pharmacological action: unknownCatalyzes the synthesis of alpha-glucan from sucrose. Catalyzes, in addition, sucrose hydrolysis, maltose and maltotriose synthesis by successive transfers of the glucosyl moiety of sucrose onto the released glucose, and finally turanose and trehalulose synthesis, these two sucrose isomers being obtained by glucosyl transfer onto fructose Organism class: bacterialUniProt ID: Q9ZEU2 ![]() Gene: ams Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]()
Pharmacological action: unknown
Provides the sole de novo source of dTMP for DNA biosynthesis. This protein also binds to its mRNA thus repressing its own translation Organism class: bacterialUniProt ID: P0A884 ![]() Gene: thyA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
D-glyceraldehyde 3-phosphate = glycerone phosphate Organism class: humanUniProt ID: P60174 ![]() Gene: TPI1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
22. Maleylacetoacetate isomerase Pharmacological action: unknownBifunctional enzyme showing minimal glutathione- conjugating activity with ethacrynic acid and 7-chloro-4- nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Has also low glutathione peroxidase activity with T- butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid Organism class: humanUniProt ID: O43708 ![]() Gene: GSTZ1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 23. 3-hydroxy-3-methylglutaryl-coenzyme A reductase Pharmacological action: unknownThis transmembrane glycoprotein is involved in the control of cholesterol biosynthesis. It is the rate-limiting enzyme of sterol biosynthesis Organism class: humanUniProt ID: P04035 ![]() Gene: HMGCR ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 24. Listeriolysin regulatory protein Pharmacological action: unknownPositively regulates expression of listeriolysin, of 1- phosphadidylinositol phosphodiesterase (PI-PLC) and other virulence factors Organism class: bacterialUniProt ID: P22262 ![]() Gene: prfA Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: |
| Comments |
|---|